ANXA11 / Annexin XI Antibody (N-Terminus)
Goat Polyclonal Antibody
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Application
| WB, IHC-P, E |
---|---|
Primary Accession | P50995 |
Reactivity | Human, Rabbit, Monkey |
Host | Goat |
Clonality | Polyclonal |
Calculated MW | 54kDa |
Dilution | ELISA (1:32000), IHC-P (3.75 µg/ml), WB (0.2-1 µg/ml) |
Gene ID | 311 |
---|---|
Other Names | Annexin A11, 56 kDa autoantigen, Annexin XI, Annexin-11, Calcyclin-associated annexin 50, CAP-50, ANXA11, ANX11 |
Target/Specificity | Human ANXA11 / Annexin A11. NP_001148.1; NP_665875.1 and NP_665876.1 are varients that encode the same protein. |
Reconstitution & Storage | Store at -20°C. Minimize freezing and thawing. |
Precautions | ANXA11 / Annexin XI Antibody (N-Terminus) is for research use only and not for use in diagnostic or therapeutic procedures. |
Name | ANXA11 |
---|---|
Synonyms | ANX11 |
Function | Binds specifically to calcyclin in a calcium-dependent manner (By similarity). Required for midbody formation and completion of the terminal phase of cytokinesis. |
Cellular Location | Cytoplasm. Melanosome. Nucleus envelope. Nucleus, nucleoplasm. Cytoplasm, cytoskeleton, spindle Note=Found throughout the nucleoplasm at interphase and during mitosis concentrates around the mitotic apparatus (By similarity). Elevation of intracellular calcium causes relocalization from the nucleoplasm to the nuclear envelope, with little effect on the cytoplasmic pool Localization to the nuclear envelope is cell-cycle dependent |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Binds specifically to calcyclin in a calcium-dependent manner (By similarity). Required for midbody formation and completion of the terminal phase of cytokinesis.
References
Misaki Y.,et al.J. Biol. Chem. 269:4240-4246(1994).
Bances P.,et al.Genomics 69:95-103(2000).
Ota T.,et al.Nat. Genet. 36:40-45(2004).
Deloukas P.,et al.Nature 429:375-381(2004).
Satoh H.,et al.Biochem. Biophys. Res. Commun. 291:1166-1172(2002).
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.